Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Ultrasound II: Endoscopic Ultrasound and FibroScan01:25

Ultrasound II: Endoscopic Ultrasound and FibroScan

Endoscopic Ultrasound (EUS) and FibroScan are valuable diagnostic tools in gastroenterology and hepatology, each with specific applications and techniques.
Endoscopic Ultrasound (EUS):

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The NPC1/USP7/p53 axis regulates cholesterol and promotes the proliferation of hepatocellular carcinoma.

Oncogene·2026
Same author

High-resolution spatial multi-omics enables prognostic scoring in intrahepatic cholangiocarcinoma.

Molecular therapy : the journal of the American Society of Gene Therapy·2026
Same author

Multilayered Regulatory Dynamics of p53 Mutations and Platinum Resistance in Ovarian Cancer.

Journal of proteome research·2025
Same author

Prevalence of DNA Mismatch Repair Deficiencies in Multiple Solid Tumor Types in China.

Journal of evidence-based medicine·2025
Same author

China Liver Cancer Guidelines for the Diagnosis and Treatment of Hepatocellular Carcinoma (2024 Edition).

Liver cancer·2025
Same author

Hepatic arterial interventional therapies alone or in combination with molecular targeted therapies and PD-(L)1 inhibitors in locally aggressive, early recurrent hepatocellular carcinoma: a retrospective study.

Frontiers in immunology·2025
Same journal

Epidemiological characteristics of amebiasis in Japan from 2001 to 2022.

PloS one·2026
Same journal

Longitudinal associations of academic stress with eating related patterns, nutrition, somatic indicators, and depressive symptoms in university students: A study protocol.

PloS one·2026
Same journal

Pollution removal efficiency enhancement by agricultural biomass additions in constructed wetlands: A framework integrating meta-analysis with explainable machine learning.

PloS one·2026
Same journal

Insulation failure mapping on power transformer bushing using FRA and electrostatic simulation.

PloS one·2026
Same journal

Enhancing medical Q&A systems with multimodal knowledge graphs and dual-layer attention mechanisms.

PloS one·2026
Same journal

UAMP: Consistent video object segmentation with uncertainty-aware memory propagation.

PloS one·2026
See all related articles

Related Experiment Video

Updated: May 8, 2026

Mouse Model of Metabolic Dysfunction-Associated Steatotic Liver Disease with Fibrosis
06:26

Mouse Model of Metabolic Dysfunction-Associated Steatotic Liver Disease with Fibrosis

Published on: July 18, 2025

Decrease of fibulin-3 in hepatocellular carcinoma indicates poor prognosis.

Rongzhen Luo1, Meifang Zhang, Lili Liu

  • 1State Key Laboratory of Oncology in Southern China, and Department of Pathology, Sun Yat-sen University Cancer Center, Guangzhou, China.

Plos One
|August 13, 2013
PubMed
Summary
This summary is machine-generated.

Fibulin-3 is downregulated in hepatocellular carcinoma (HCC), acting as an antitumor protein. Low Fibulin-3 expression indicates poor prognosis and increased invasiveness in HCC patients, highlighting its potential as a biomarker.

More Related Videos

Mast Cells in the Microenvironment of Hepatocellular Carcinoma Confer Favorable Prognosis: A Retrospective Study using QuPath Image Analysis Software
07:32

Mast Cells in the Microenvironment of Hepatocellular Carcinoma Confer Favorable Prognosis: A Retrospective Study using QuPath Image Analysis Software

Published on: April 12, 2024

A Biomimetic Model for Liver Cancer to Study Tumor-Stroma Interactions in a 3D Environment with Tunable Bio-Physical Properties
08:40

A Biomimetic Model for Liver Cancer to Study Tumor-Stroma Interactions in a 3D Environment with Tunable Bio-Physical Properties

Published on: August 7, 2020

Related Experiment Videos

Last Updated: May 8, 2026

Mouse Model of Metabolic Dysfunction-Associated Steatotic Liver Disease with Fibrosis
06:26

Mouse Model of Metabolic Dysfunction-Associated Steatotic Liver Disease with Fibrosis

Published on: July 18, 2025

Mast Cells in the Microenvironment of Hepatocellular Carcinoma Confer Favorable Prognosis: A Retrospective Study using QuPath Image Analysis Software
07:32

Mast Cells in the Microenvironment of Hepatocellular Carcinoma Confer Favorable Prognosis: A Retrospective Study using QuPath Image Analysis Software

Published on: April 12, 2024

A Biomimetic Model for Liver Cancer to Study Tumor-Stroma Interactions in a 3D Environment with Tunable Bio-Physical Properties
08:40

A Biomimetic Model for Liver Cancer to Study Tumor-Stroma Interactions in a 3D Environment with Tunable Bio-Physical Properties

Published on: August 7, 2020

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Fibulin-3 is involved in cell functions and has dual roles in cancer.
  • Its specific function in hepatocellular carcinoma (HCC) is not well understood.

Purpose of the Study:

  • To investigate the role and prognostic significance of Fibulin-3 in hepatocellular carcinoma (HCC).

Main Methods:

  • Analyzed Fibulin-3 mRNA and protein levels in HCC cell lines and tissues.
  • Utilized immunohistochemistry to assess Fibulin-3 expression in 255 HCC cases.
  • Performed statistical analyses including ROC, Kaplan-Meier, and multivariate analysis.
  • Conducted in vitro experiments using siRNA to knockdown Fibulin-3.

Main Results:

  • Fibulin-3 expression was significantly downregulated in HCC tissues and cell lines.
  • Low Fibulin-3 expression correlated with poor tumor differentiation, advanced clinical stage, and elevated AFP levels.
  • Fibulin-3 is an independent negative prognostic indicator for overall and recurrence-free survival in HCC.
  • Knockdown of Fibulin-3 increased HCC cell viability and invasion.

Conclusions:

  • Fibulin-3 exhibits antitumor properties in HCC.
  • Decreased Fibulin-3 expression serves as a biomarker for unfavorable prognosis in hepatocellular carcinoma.